|
Dartmouth physicians and engineers have
published a paper with results from a five-year project
testing three new imaging techniques to examine breast
abnormalities, including cancer. The study finds that
the new methods of electromagnetic imaging offer a
high contrast and the ability to distinguish between
healthy breast tissue and abnormal tissue. Their study
appears in the May 2007 issue of Radiology, the journal
of the Radiological Society of North America.
Read
more
In an unexpected about face, folic acid
supplementation does not decrease the risk of benign
colorectal tumors, and may possibly increase risk for
some types of these lesions, also called polyps, Dartmouth
Medical School and Norris Cotton Cancer Center researchers
have found.
Read
more
In one of the three most common back
conditions for which patients seek treatment, surgery
proved to have substantially better results than non-surgical
remedies, according to Dartmouth-led research published
in the May 31 New England Journal of Medicine. The
paper is the second in a series detailing the findings
of the Spine Patient Outcomes Research Trial (SPORT),
a seven-year, $21 million national study funded by
the National Institutes of Health.
Read
more
- Dartmouth Medicine Magazine Spring
2007
It's distressing for a woman to learn
that she has breast cancer, even if it is caught early.
First comes the shock of the diagnosis. Then comes
the realization, if she has early-stage cancer, that
she has to choose between two treatments with similar
long-term survival: a total mastectomy or breast-conserving
surgery followed by radiation therapy.
Read
more
- Dartmouth Medicine
Magazine Spring 2007
A recent Dartmouth study in the Journal
of the National Cancer Institute showed that calcium
may provide some protective effect against colorectal
cancer. John Baron, M.D., and colleagues examined data
from an earlier trial that had randomly assigned 930
patients with a recent adenoma to take either a placebo
or a 1200-mg calcium supplement.
Read
More
- News@Dartmouth March
2007
Sorting through the evidence about aspirin's
benefits for women can be confounding, according to
a Dartmouth Medical School physician.
New findings that women who take low
to moderate doses of aspirin have a reduced risk of
death, and especially heart disease-related deaths,
are provocative.
Read more
- Vox of Dartmouth-
January 2007
Dartmouth Medical School (DMS) researchers
have identified a new way that arsenite, a form of
arsenic, acts in treating a rare cancer known as APL,
or acute promyelocytic leukemia. Their study is published
in the Jan. 3 issue of the Journal of the National
Cancer Institute.
"We knew that arsenite was particularly
effective against this cancer, and we wanted to figure
out why," says Sutisak Kitareewan, an author on
this paper and an instructor of pharmacology and toxicology
at DMS. Read more
- Dartmouth Medicine
Magazine Winter 2006
Light aspirin, with its growing record
of benefit to heart and colon health, also protect
against common skin cancers? Not to any great extent
was the conclusion of a recent study by researchers
in DMS's Department of Community and Family Medicine.
Maria Grau, M.D., M.P.H., was the first
author on the paper, which was published in the International
Journal of Cancer.
Read
more
|
